Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mercury ions (Hg₂²⁺ and Hg²⁺) are cationic forms of mercury. They are highly toxic environmental pollutants that can disrupt various biological processes. While not direct therapeutic targets, their presence necessitates the use of chelating agents to mitigate their toxic effects. Mercury ions primarily exert their toxicity through mechanisms such as enzyme inhibition and protein precipitation.
Chelating agents bind to mercury ions, forming stable complexes that can be excreted from the body.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mercury Ion.